PubRank
Search
About
Deborah A Bowen
Author PubWeight™ 18.94
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia.
Leuk Lymphoma
2011
1.71
2
Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
Leuk Lymphoma
2012
1.61
3
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.
Br J Haematol
2008
1.33
4
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
J Clin Oncol
2009
1.33
5
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
Br J Haematol
2007
1.32
6
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
Cancer
2008
1.29
7
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Br J Haematol
2008
1.29
8
Validation of a new prognostic index for patients with chronic lymphocytic leukemia.
Cancer
2009
1.24
9
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.
Cancer
2012
1.22
10
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.
Leuk Lymphoma
2009
0.98
11
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Cancer
2011
0.95
12
Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes.
Haematologica
2013
0.91
13
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.
Am J Hematol
2014
0.86
14
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Leuk Lymphoma
2014
0.85
15
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia.
Leuk Res
2008
0.85
16
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia.
Leuk Lymphoma
2010
0.83
17
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.
Br J Haematol
2013
0.82